<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33068411</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>21</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>02</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>RNA as the stone guest of protein aggregation.</ArticleTitle><Pagination><StartPage>11880</StartPage><EndPage>11889</EndPage><MedlinePgn>11880-11889</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa822</ELocationID><Abstract><AbstractText>The study of prions as infectious aggregates dates several decades. From its original formulation, the definition of a prion has progressively changed to the point that many aggregation-prone proteins are now considered bona fide prions. RNA molecules, not included in the original 'protein-only hypothesis', are also being recognized as important factors contributing to the 'prion behaviour', that implies the transmissibility of an aberrant fold. In particular, an association has recently emerged between aggregation and the assembly of prion-like proteins in RNA-rich complexes, associated with both physiological and pathological events. Here, we discuss the historical rising of the concept of prion-like domains, their relation to RNA and their role in protein aggregation. As a paradigmatic example, we present the case study of TDP-43, an RNA-binding prion-like protein associated with amyotrophic lateral sclerosis. Through this example, we demonstrate how the current definition of prions has incorporated quite different concepts making the meaning of the term richer and more stimulating. An important message that emerges from our analysis is the dual role of RNA in protein aggregation, making RNA, that has been considered for many years a 'silent presence' or the 'stone guest' of protein aggregation, an important component of the process.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Louka</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the Maurice Wohl Institute of King's College London, London SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacco</LastName><ForeName>Elsa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Human Technologies, Central RNA laboratory, Istituto Italiano di Tecnologia, Genova 16152, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temussi</LastName><ForeName>Piero Andrea</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the Maurice Wohl Institute of King's College London, London SE5 9RT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University "Federico II'' Napoli, via Cynthia, Napoli 80100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tartaglia</LastName><ForeName>Gian Gaetano</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Center for Human Technologies, Central RNA laboratory, Istituto Italiano di Tecnologia, Genova 16152, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona 08003, Spain and ICREA, 23 Passeig Llu&#x131;s Companys, Barcelona 08010, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles Darwin department of Biology and Biotechnology, Sapienza University of Rome, Piazzale A. Moro 5, Rome 00185, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastore</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the Maurice Wohl Institute of King's College London, London SE5 9RT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_13054</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>PASTORE/APR15/840-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C102041">TAF15 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035381">TATA-Binding Protein Associated Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="N">Prions</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072756" MajorTopicYN="N">Protein Conformation, alpha-Helical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072757" MajorTopicYN="N">Protein Conformation, beta-Strand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035381" MajorTopicYN="N">TATA-Binding Protein Associated Factors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>17</Day><Hour>17</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33068411</ArticleId><ArticleId IdType="pmc">PMC7708036</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa822</ArticleId><ArticleId IdType="pii">5929225</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wickner R.B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science. 1994; 264:566&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pubmed">7909170</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science. 1982; 216:136&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">6801762</ArticleId></ArticleIdList></Reference><Reference><Citation>Alper T., Cramp W.A., Haig D.A., Clarke M.C.. Does the agent of scrapie replicate without nucleic acid. Nature. 1967; 214:764&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">4963878</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajdusek D.C. Transthyretin amyloidoses of familial amyloidotic polyneuropathy as a paradigm for the genetic control of spontaneous generation of infectious amyloids by patterned configurational change in host precursors in Creutzfeldt-Jacob disease. Acta Med. Port. 1991; 4:9S&#x2013;15S.</Citation><ArticleIdList><ArticleId IdType="pubmed">1805538</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner S.B. Molecular biology and genetics of prion diseases. Philos. Trans. R. Soc. London Ser. B, Biol. Sci. 1994; 343:447&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">7913765</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocisko D.A., Come J.H., Priola S.A., Chesebro B., Raymond G.J., Lansbury P.T., Caughey B.. Cell-free formation of protease-resistant prion protein. Nature. 1994; 370:471&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">7913989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter G.D., Millson G.C.. Further experiments on the comparative potency of tissue extracts from mice infected with scrapie. Res. Vet. Sci. 1964; 5:149&#x2013;153.</Citation></Reference><Reference><Citation>Alper T., Haig D.A., Clarke M.C.. The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun. 1966; 22:278&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">4957205</ArticleId></ArticleIdList></Reference><Reference><Citation>Oesch B., Westaway D., W&#xe4;lchli M., McKinley M.P., Kent S.B., Aebersold R., Barry R.A., Tempst P., Teplow D.B., Hood L.E.. A cellular gene encodes scrapie PrP 27&#x2013;30 protein. Cell. 1985; 40:735&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">2859120</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesebro B., Race R., Wehrly K., Nishio J., Bloom M., Lechner D., Bergstrom S., Robbins K., Mayer L., Keith J.M. et al. .. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature. 1985; 315:331&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">3923361</ArticleId></ArticleIdList></Reference><Reference><Citation>Locht C., Chesebro B., Race R., Keith J.M.. Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc. Natl. Acad. Sci. U.S.A. 1986; 83:6372&#x2013;6376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC386505</ArticleId><ArticleId IdType="pubmed">3462700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke P.C., Zhou R., Serpell L.C., Riek R., Knowles T.P.J., Lashuel H.A., Gazit E., Hamley I.W., Davis T.P., F&#xe4;ndrich M. et al. .. Half a century of amyloids: past, present and future. Chem. Soc. Rev. 2020; 49:5473&#x2013;5509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445747</ArticleId><ArticleId IdType="pubmed">32632432</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson C.M. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. London. Ser. B, Biol. Sci. 2001; 356:133&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1088418</ArticleId><ArticleId IdType="pubmed">11260793</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson C.M. Protein folding and its links with human disease. Biochem. Soc. Symp. 2001; 68:1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">11573341</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E.. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. 1993; 90:10962&#x2013;10966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC47901</ArticleId><ArticleId IdType="pubmed">7902575</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabate R., Rousseau F., Schymkowitz J., Ventura S.. What makes a protein sequence a prion. PLoS Comput. Biol. 2015; 11:e1004013&#x2013;e1004013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4288708</ArticleId><ArticleId IdType="pubmed">25569335</ArticleId></ArticleIdList></Reference><Reference><Citation>Baral P.K., Yin J., Aguzzi A., James M.N.G.. Transition of the prion protein from a structured cellular form (PrPC) to the infectious scrapie agent (PrPSc). Protein Sci. 2019; 28:2055&#x2013;2063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6863700</ArticleId><ArticleId IdType="pubmed">31583788</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez J.A., Jiang L., Eisenberg D.S.. Toward the atomic structure of PrP(Sc). Cold Spring Harb. Perspect. Biol. 2017; 9:a031336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585850</ArticleId><ArticleId IdType="pubmed">28096267</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamborough P., Wille H., Telling G.C., Yehiely F., Prusiner S.B., Cohen F.E.. Prion protein structure and scrapie replication: theoretical, spectroscopic, and genetic investigations. Cold Spring Harbor Symposia on Quantitative Biology. 1996; 61:Cold Spring Harbor Laboratory Press; 495&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">9246476</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig B., Altmeppen H., Glatzel M.. The GPI-anchoring of PrP: implications in sorting and pathogenesis. Prion. 2014; 8:11&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7030901</ArticleId><ArticleId IdType="pubmed">24509692</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig B., Altmeppen H.C., Linsenmeier L., Chakroun K., Wegwitz F., Piontek U.K., Tatzelt J., Bate C., Magnus T., Glatzel M.. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice. PLoS Pathog. 2019; 15:e1007520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6334958</ArticleId><ArticleId IdType="pubmed">30608982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastore A., Zagari A.. A structural overview of the vertebrate prion proteins. Prion. 2007; 1:185&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634592</ArticleId><ArticleId IdType="pubmed">19164911</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo-Morantes C.Y., Wille H.. The structure of human prions: from biology to structural models-considerations and pitfalls. Viruses. 2014; 6:3875&#x2013;3892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4213568</ArticleId><ArticleId IdType="pubmed">25333467</ArticleId></ArticleIdList></Reference><Reference><Citation>Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., W&#xfc;thrich K.. NMR structure of the mouse prion protein domain PrP(121-231). Nature. 1996; 382:180&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">8700211</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostol M.I., Wiltzius J.J.W., Sawaya M.R., Cascio D., Eisenberg D.. Atomic structures suggest determinants of transmission barriers in mammalian prion disease. Biochemistry. 2011; 50:2456&#x2013;2463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3068218</ArticleId><ArticleId IdType="pubmed">21323366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., Apostol M.I., Thompson M.J., Balbirnie M., Wiltzius J.J.W., McFarlane H.T. et al. .. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature. 2007; 447:453&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">17468747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes D., Halliday M.. What is our current understanding of PrP(Sc)-associated neurotoxicity and its molecular underpinnings. Pathog. (Basel, Switzerland). 2017; 6:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5750587</ArticleId><ArticleId IdType="pubmed">29194372</ArticleId></ArticleIdList></Reference><Reference><Citation>Govaerts C., Wille H., Prusiner S.B., Cohen F.E.. Evidence for assembly of prions with left-handed &#x3b2;-helices into trimers. Proc. Natl. Acad. Sci. U.S.A. 2004; 101:8342&#x2013;8347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC420396</ArticleId><ArticleId IdType="pubmed">15155909</ArticleId></ArticleIdList></Reference><Reference><Citation>Langedijk J.P.M., Fuentes G., Boshuizen R., Bonvin A.M.J.J.. Two-rung model of a left-handed &#x3b2;-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies. J. Mol. Biol. 2006; 360:907&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pubmed">16782127</ArticleId></ArticleIdList></Reference><Reference><Citation>Groveman B.R., Dolan M.A., Taubner L.M., Kraus A., Wickner R.B., Caughey B.. Parallel in-register intermolecular &#x3b2;-sheet architectures for prion-seeded prion protein (PrP) amyloids. J. Biol. Chem. 2014; 289:24129&#x2013;24142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4148845</ArticleId><ArticleId IdType="pubmed">25028516</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.-Q., Zhao K., Yuan H.-Y., Wang Q., Zeyuan G., Tao J., Li X.-N., Sun Y., Yi C.-W., Chen J. et al. .. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein. Nat. Struct. Mol. Biol. 2020; 27:598&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">32514176</ArticleId></ArticleIdList></Reference><Reference><Citation>Wille H., Requena J.R.. The structure of PrP(Sc) prions. Pathog. (Basel, Switzerland). 2018; 7:20.</Citation></Reference><Reference><Citation>Prigent S., Rezaei H.. PrP assemblies: spotting the responsible regions in prion propagation. Prion. 2011; 5:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3166504</ArticleId><ArticleId IdType="pubmed">21788728</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B., McDonald A.J., Markham K., Rich C.B., McHugh K.P., Tatzelt J., Colby D.W., Millhauser G.L., Harris D.A.. The N-terminus of the prion protein is a toxic effector regulated by the C-terminus. Elife. 2017; 6:e23473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5469617</ArticleId><ArticleId IdType="pubmed">28527237</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez J., S&#xe1;nchez R., Castellanos M., Makarava N., Aguzzi A., Baskakov I.V., Gasset M.. PrP charge structure encodes interdomain interactions. Sci. Rep. 2015; 5:13623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4555102</ArticleId><ArticleId IdType="pubmed">26323476</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner S.B. Biology and genetics of prions causing neurodegeneration. Annu. Rev. Genet. 2013; 47:601&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010318</ArticleId><ArticleId IdType="pubmed">24274755</ArticleId></ArticleIdList></Reference><Reference><Citation>Glatzel M., Abela E., Maissen M., Aguzzi A.. Extraneural pathologic prion protein in sporadic Creutzfeldt&#x2013;Jakob disease. N. Engl. J. Med. 2003; 349:1812&#x2013;1820.</Citation><ArticleIdList><ArticleId IdType="pubmed">14602879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu P.P., Morales R., Duran-Aniotz C., Moreno-Gonzalez I., Khan U., Soto C.. Role of prion replication in the strain-dependent brain regional distribution of prions. J. Biol. Chem. 2016; 291:12880&#x2013;12887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933468</ArticleId><ArticleId IdType="pubmed">27056328</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A.F., Antoniou M., Collinge J.. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 1999; 80:11&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">9934677</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko K., Zulianello L., Scott M., Cooper C.M., Wallace A.C., James T.L., Cohen F.E., Prusiner S.B.. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prionpropagation. Proc. Natl. Acad. Sci. U S A. 1997; 94:10069&#x2013;10074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23307</ArticleId><ArticleId IdType="pubmed">9294164</ArticleId></ArticleIdList></Reference><Reference><Citation>Caughey B., Kocisko D.A.. Prion diseases: a nucleic-acid accomplice. Nature. 2003; 425:673&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">14562085</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J.L., Lima L.M.T.R., Foguel D., Cordeiro Y.. Intriguing nucleic-acid-binding features of mammalian prion protein. Trends Biochem. Sci. 2008; 33:132&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">18243708</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J.L., Cordeiro Y.. The &#x201c;Jekyll and Hyde" Actionsof Nucleic Acids on the Prion-likeAggregation of Proteins. J. Biol. Chem. 2016; 291:15482&#x2013;15490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4957035</ArticleId><ArticleId IdType="pubmed">27288413</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke C.M., Walsh D.J., Steele A.D., Agrimi U., Di&#xa0;Bari M.A., Watts J.C., Supattapone S.. Full restoration of specific infectivity and strain properties from pure mammalian prion protein. PLoS Pathog. 2019; 15:e1007662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6448948</ArticleId><ArticleId IdType="pubmed">30908557</ArticleId></ArticleIdList></Reference><Reference><Citation>Deleault N.R., Lucassen R.W., Supattapone S.. RNA molecules stimulate prion protein conversion. Nature. 2003; 425:717&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">14562104</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskakov I. V, Legname G., Prusiner S.B., Cohen F.E.. Folding of prion protein to its native alpha-helical conformation is under kinetic control. J. Biol. Chem. 2001; 276:19687&#x2013;19690.</Citation><ArticleIdList><ArticleId IdType="pubmed">11306559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordeiro Y., Silva J.L.. The hypothesis of the catalytic action of nucleic acid on the conversion of prion protein. Protein Pept. Lett. 2005; 12:251&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">15777274</ArticleId></ArticleIdList></Reference><Reference><Citation>Cid-Samper F., Gelabert-Baldrich M., Lang B., Lorenzo-Gotor N., Ponti R.D., Severijnen L.-A.W.F.M., Bolognesi B., Gelpi E., Hukema R.K., Botta-Orfila T. et al. .. An integrative study of protein-RNA condensates identifies scaffolding RNAs and reveals players in fragile X-associated tremor/ataxia syndrome. Cell Rep. 2018; 25:3422&#x2013;3434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6315285</ArticleId><ArticleId IdType="pubmed">30566867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez&#xa0;de&#xa0;Groot N., Armaos A., Gra&#xf1;a-Montes R., Alriquet M., Calloni G., Vabulas R.M., Tartaglia G.G.. RNA structure drives interaction with proteins. Nat. Commun. 2019; 10:3246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642211</ArticleId><ArticleId IdType="pubmed">31324771</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhie A., Kirby L., Sayer N., Wellesley R., Disterer P., Sylvester I., Gill A., Hope J., James W., Tahiri-Alaoui A.. Characterization of 2&#x2032;-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J. Biol. Chem. 2003; 278:39697&#x2013;39705.</Citation><ArticleIdList><ArticleId IdType="pubmed">12902353</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayer N.M., Cubin M., Rhie A., Bullock M., Tahiri-Alaoui A., James W.. Structural determinants of conformationally selective, prion-binding aptamers. J. Biol. Chem. 2004; 279:13102&#x2013;13109.</Citation><ArticleIdList><ArticleId IdType="pubmed">14711834</ArticleId></ArticleIdList></Reference><Reference><Citation>King D.J., Safar J.G., Legname G., Prusiner S.B.. Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites. J. Mol. Biol. 2007; 369:1001&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pubmed">17481659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi P.K. Interaction of prion peptide HuPrP106&#x2013;126 with nucleic acid. Arch. Virol. 1997; 142:2537&#x2013;2545.</Citation><ArticleIdList><ArticleId IdType="pubmed">9672613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovachev P.S., Gomes M.P.B., Cordeiro Y., Ferreira N.C., Valad&#xe3;o L.P.F., Ascari L.M., Rangel L.P., Silva J.L., Sanyal S.. RNA modulates aggregation of the recombinant mammalian prion protein by direct interaction. Sci. Rep. 2019; 9:12406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6712051</ArticleId><ArticleId IdType="pubmed">31455808</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzmann T.M., Alberti S.. Protein phase separation as a stress survival strategy. Cold Spring Harb. Perspect. Biol. 2019; 11:a034058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6546044</ArticleId><ArticleId IdType="pubmed">30617047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordeiro Y., Kraineva J., Gomes M.P.B., Lopes M.H., Martins V.R., Lima L.M.T.R., Foguel D., Winter R., Silva J.L.. The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation. Biophys. J. 2005; 89:2667&#x2013;2676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1366767</ArticleId><ArticleId IdType="pubmed">16040743</ArticleId></ArticleIdList></Reference><Reference><Citation>Masison D.C., Wickner R.B.. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science. 1995; 270:93&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">7569955</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A., Rajendran L.. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron. 2009; 64:783&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20064386</ArticleId></ArticleIdList></Reference><Reference><Citation>Verges K.J., Smith M.H., Toyama B.H., Weissman J.S.. Strain conformation, primary structure and the propagation of the yeast prion [PSI+]. Nat. Struct. Mol. Biol. 2011; 18:493&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3490428</ArticleId><ArticleId IdType="pubmed">21423194</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabortee S., Byers J.S., Jones S., Garcia D.M., Bhullar B., Chang A., She R., Lee L., Fremin B., Lindquist S. et al. .. Intrinsically disordered proteins drive emergence and inheritance of biological traits. Cell. 2016; 167:369&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5066306</ArticleId><ArticleId IdType="pubmed">27693355</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbi D., Harrison P.M.. Interaction networks of prion, prionogenic and prion-like proteins in budding yeast, and their role in gene regulation. PLoS One. 2014; 9:e100615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4074094</ArticleId><ArticleId IdType="pubmed">24972093</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison P.M. fLPS: fast discovery of compositional biases for the protein universe. BMC Bioinformatics. 2017; 18:476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5684748</ArticleId><ArticleId IdType="pubmed">29132292</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann R., Alberti S., Krishnan R., Lyle N., O&#x2019;Donnell C.W., King O.D., Berger B., Pappu R.V., Lindquist S.. Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins. Mol. Cell. 2011; 43:72&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3132398</ArticleId><ArticleId IdType="pubmed">21726811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster A.K., Nutter-Upham A., Lindquist S., King O.D.. PLAAC: a web and command-line application to identify proteins with prion-like amino acid composition. Bioinformatics. 2014; 30:2501&#x2013;2502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4147883</ArticleId><ArticleId IdType="pubmed">24825614</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa&#xa0;Angarica V., Ventura S., Sancho J.. Discovering putative prion sequences in complete proteomes using probabilistic representations of Q/N-rich domains. BMC Genomics. 2013; 14:316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3654983</ArticleId><ArticleId IdType="pubmed">23663289</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetz G., Tetz V.. Prion-Like domains in phagobiota. Front. Microbiol. 2017; 8:2239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5694896</ArticleId><ArticleId IdType="pubmed">29187840</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetz G., Tetz V.. Bacteriophages as new human viral pathogens. Microorganisms. 2018; 6:54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027513</ArticleId><ArticleId IdType="pubmed">29914145</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison P.M. Evolutionary behaviour of bacterial prion-like proteins. PLoS One. 2019; 14:e0213030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6400439</ArticleId><ArticleId IdType="pubmed">30835736</ArticleId></ArticleIdList></Reference><Reference><Citation>Toombs J.A., Petri M., Paul K.R., Kan G.Y., Ben-Hur A., Ross E.D.. De novo design of synthetic prion domains. Proc. Natl. Acad. Sci. U.S.A. 2012; 109:6519&#x2013;6524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3340034</ArticleId><ArticleId IdType="pubmed">22474356</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartaglia G.G., Pawar A.P., Campioni S., Dobson C.M., Chiti F., Vendruscolo M.. Prediction of aggregation-prone regions in structured proteins. J. Mol. Biol. 2008; 380:425&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">18514226</ArticleId></ArticleIdList></Reference><Reference><Citation>Saupe S.J. The [Het-s] prion of Podospora anserina and its role in heterokaryon incompatibility. Seminars in Cell &amp; Developmental Biology. 2011; 22:Elsevier; 460&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">21334447</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison C.F., Lawson V.A., Coleman B.M., Kim Y.S., Masters C.L., Cappai R., Barnham K.J., Hill A.F.. Conservation of a glycine-rich region in the prion protein is required foruptake of prion infectivity. J. Biol. Chem. 2010; 285:20213&#x2013;20223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2888434</ArticleId><ArticleId IdType="pubmed">20356832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehsani S., Tao R., Pocanschi C.L., Ren H., Harrison P.M., Schmitt-Ulms G.. Evidence for retrogene origins of the prion gene family. PLoS One. 2011; 6:e26800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203146</ArticleId><ArticleId IdType="pubmed">22046361</ArticleId></ArticleIdList></Reference><Reference><Citation>Westaway D., Genovesi S., Daude N., Brown R., Lau A., Lee I., Mays C.E., Coomaraswamy J., Canine B., Pitstick R. et al. .. Down-regulation of Shadoo in prion infections traces a pre-clinical event inversely related to PrP(Sc) accumulation. PLoS Pathog. 2011; 7:e1002391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219720</ArticleId><ArticleId IdType="pubmed">22114562</ArticleId></ArticleIdList></Reference><Reference><Citation>March Z.M., King O.D., Shorter J.. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res. 2016; 1647:9&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003744</ArticleId><ArticleId IdType="pubmed">26996412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer B.C., Schuck T., Wheeler J.M., Robinson L.C., Trojanowski J.Q., Lee V.M.Y., Schellenberg G.D.. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 2010; 119:409&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2880609</ArticleId><ArticleId IdType="pubmed">20198480</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Good S.K., Atkin S., Dewey C.M., Mayer P. 3rd, Herz J., Yu G.. TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem. 2010; 285:6826&#x2013;6834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2825476</ArticleId><ArticleId IdType="pubmed">20040602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Birsoy K., Hughes N.W., Krupczak K.M., Post Y., Wei J.J., Lander E.S., Sabatini D.M.. Identification and characterization of essential genes in the human genome. Science. 2015; 350:1096&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4662922</ArticleId><ArticleId IdType="pubmed">26472758</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.R., King O.D., Shorter J., Gitler A.D.. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013; 201:361&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>King O.D., Gitler A.D., Shorter J.. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012; 1462:61&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372647</ArticleId><ArticleId IdType="pubmed">22445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotor N.L., Armaos A., Calloni G., Vabulas R.M., de&#xa0;Groot N.S., Tartaglia G.G.. RNA-binding and prion domains: the yin and yang of phase separation. Nucleic Acids Res. 2020; 48:9491&#x2013;9504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7515694</ArticleId><ArticleId IdType="pubmed">32857852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S., Wheeler J.R., Walters R.W., Agrawal A., Barsic A., Parker R.. ATPase-Modulated stress granules contain a diverse proteome and substructure. Cell. 2016; 164:487&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4733397</ArticleId><ArticleId IdType="pubmed">26777405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B. Regulated protein aggregation: stress granules and neurodegeneration. Mol. Neurodegener. 2012; 7:56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3519755</ArticleId><ArticleId IdType="pubmed">23164372</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.-L., Dickson D.W., Petrucelli L., Zhang T., Wang X.. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013; 22:4706&#x2013;4719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Banfi S., Servadio A., Chung M.Y., Kwiatkowski T.J.J., McCall A.E., Duvick L.A., Shen Y., Roth E.J., Orr H.T., Zoghbi H.Y.. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat. Genet. 1994; 7:513&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">7951322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugras S.E., Shorter J.. RNA-binding proteins in amyotrophic lateral sclerosis and neurodegeneration. Neurol. Res. Int. 2012; 2012:432780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3423945</ArticleId><ArticleId IdType="pubmed">22919483</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S., Wang J., Papadopoulos D.K., Richter D., Pozniakovsky A., Poser I., Bickle M., Rizk S., Guill&#xe9;n-Boixet J., Franzmann T.M. et al. .. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science (80-.). 2018; 360:918&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzmann T.M., Jahnel M., Pozniakovsky A., Mahamid J., Holehouse A.S., N&#xfc;ske E., Richter D., Baumeister W., Grill S.W., Pappu R. V et al. .. Phase separation of a yeast prion protein promotes cellular fitness. Science (80-.). 2018; 359:eaao5654.</Citation><ArticleIdList><ArticleId IdType="pubmed">29301985</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentze M.W., Castello A., Schwarzl T., Preiss T.. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 2018; 19:327&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">29339797</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S., Halfmann R., King O., Kapila A., Lindquist S.. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell. 2009; 137:146&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2683788</ArticleId><ArticleId IdType="pubmed">19345193</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrea D.M., Cika J.A., Guy C.S., Ban D., Banerjee P.R., Stanley C.B., Nourse A., Deniz A.A., Kriwacki R.W.. Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA. Elife. 2016; 5:e13571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4786410</ArticleId><ArticleId IdType="pubmed">26836305</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann J.R., Gleixner A.M., Mauna J.C., Gomes E., DeChellis-Marks M.R., Needham P.G., Copley K.E., Hurtle B., Portz B., Pyles N.J. et al. .. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019; 102:321&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann B.M., Horos R., Fischer B., Castello A., Eichelbaum K., Alleaume A.-M., Schwarzl T., Curk T., Foehr S., Huber W. et al. .. The RNA-binding proteomes from yeast to man harbour conserved enigmRBPs. Nat. Commun. 2015; 6:10127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4686815</ArticleId><ArticleId IdType="pubmed">26632259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo P.-H., Doudeva L.G., Wang Y.-T., Shen C.-K.J., Yuan H.S.. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res. 2009; 37:1799&#x2013;1808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2665213</ArticleId><ArticleId IdType="pubmed">19174564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Plotkin A.S., Lee V.M.-Y., Trojanowski J.Q.. TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 2010; 6:211&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., Gitler A.D.. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 2009; 284:20329&#x2013;20339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Polymenidou M., Cleveland D.W.. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013; 79:416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M. et al. .. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Shanware N.P., Bowler M.J., Tibbetts R.S.. Amyotrophic lateral Sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to Co-regulate HDAC6 mRNA. J. Biol. Chem. 2010; 285:34097&#x2013;34105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2962508</ArticleId><ArticleId IdType="pubmed">20720006</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E.. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 2001; 276:36337&#x2013;36343.</Citation><ArticleIdList><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Brindisi A., Pagani F., Baralle F.E.. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am. J. Hum. Genet. 2004; 74:1322&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1182100</ArticleId><ArticleId IdType="pubmed">15195661</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M., Buratti E., Stuani C., Guarnaccia C., Romano V., De&#xa0;Conti L., Baralle F.E.. Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region. J. Biol. Chem. 2012; 287:7512&#x2013;7525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3293573</ArticleId><ArticleId IdType="pubmed">22235134</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognesi B., Lorenzo&#xa0;Gotor N., Dhar R., Cirillo D., Baldrighi M., Tartaglia G.G., Lehner B.. A concentration-dependent liquid phase separation can cause toxicity upon increased protein expression. Cell Rep. 2016; 16:222&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4929146</ArticleId><ArticleId IdType="pubmed">27320918</ArticleId></ArticleIdList></Reference><Reference><Citation>Loughlin F.E., Wilce J.A.. TDP-43 and FUS-structural insights into RNA recognition and self-association. Curr. Opin. Struct. Biol. 2019; 59:134&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">31479821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacco E., Martin S.R., Thorogate R., Pastore A.. The RNA-recognition motifs of TAR DNA-binding protein 43 may play a role in the aberrant self-assembly of the protein. Front. Mol. Neurosci. 2018; 11:372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6190850</ArticleId><ArticleId IdType="pubmed">30356856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacco E., Gra&#xf1;a-Montes R., Martin S.R., de&#xa0;Groot N.S., Alfano C., Tartaglia G.G., Pastore A.. RNA as a key factor in driving or preventing self-assembly of the TAR DNA-binding protein 43. J. Mol. Biol. 2019; 431:1671&#x2013;1688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6461199</ArticleId><ArticleId IdType="pubmed">30742796</ArticleId></ArticleIdList></Reference><Reference><Citation>Masino L., Nicastro G., Calder L., Vendruscolo M., Pastore A.. Functional interactions as a survival strategy against abnormal aggregation. FASEB J. 2011; 25:45&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3005437</ArticleId><ArticleId IdType="pubmed">20810784</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesiridis G.S., Tripathy K., Tanik S., Trojanowski J.Q., Lee V.M.-Y.. A &#x2018;two-hit&#x2019; hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport. J. Biol. Chem. 2011; 286:18845&#x2013;18855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3099701</ArticleId><ArticleId IdType="pubmed">21454607</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa S., Nojima N., Yoshida K., Hirayama S., Ogihara H., Morinaga Y.. The importance of inter-species cell-cell co-aggregation between Lactobacillus plantarum ML11-11 and Saccharomyces cerevisiae BY4741 in mixed-species biofilm formation. Biosci. Biotechnol. Biochem. 2011; 75:1430&#x2013;1434.</Citation><ArticleIdList><ArticleId IdType="pubmed">21821955</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Arslan P.E., Won A., Yip C.M., Chakrabartty A.. Binding of TDP-43 to the 3&#x2019;UTR of its cognate mRNA enhances its solubility. Biochemistry. 2014; 53:5885&#x2013;5894.</Citation><ArticleIdList><ArticleId IdType="pubmed">25171271</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirillo D., Agostini F., Klus P., Marchese D., Rodriguez S., Bolognesi B., Tartaglia G.G.. Neurodegenerative diseases: quantitative predictions of protein-RNA interactions. RNA. 2013; 19:129&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3543085</ArticleId><ArticleId IdType="pubmed">23264567</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-J., Topp S.D., Hui H.S., Zacco E., Katarya M., McLoughlin C., King A., Smith B.N., Troakes C., Pastore A. et al. .. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy. Brain. 2019; 142:3753&#x2013;3770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6885686</ArticleId><ArticleId IdType="pubmed">31605140</ArticleId></ArticleIdList></Reference><Reference><Citation>Anthony K., Gallo J.-M.. Aberrant RNA processing events in neurological disorders. Brain Res. 2010; 1338:67&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">20226177</ArticleId></ArticleIdList></Reference><Reference><Citation>Docter B.E., Horowitz S., Gray M.J., Jakob U., Bardwell J.C.A.. Do nucleic acids moonlight as molecular chaperones. Nucleic Acids Res. 2016; 44:4835&#x2013;4845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4889950</ArticleId><ArticleId IdType="pubmed">27105849</ArticleId></ArticleIdList></Reference><Reference><Citation>Prischi F., Pastore C., Carroni M., Iannuzzi C., Adinolfi S., Temussi P., Pastore A.. Of the vulnerability of orphan complex proteins: the case study of the E. coli IscU and IscS proteins. Protein Expr. Purif. 2010; 73:161&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">20471481</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastore A., Temussi P.A.. The two faces of Janus: functional interactions and protein aggregation. Curr. Opin. Struct. Biol. 2012; 22:30&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">22155180</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannuzzi C., Adrover M., Puglisi R., Yan R., Temussi P.A., Pastore A.. The role of zinc in the stability of the marginally stable IscU scaffold protein. Protein Sci. 2014; 23:1208&#x2013;1219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4243993</ArticleId><ArticleId IdType="pubmed">24917298</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>